Matan Geron's Avatar

Matan Geron

@mgeron

Postdoc in the Scherrer lab at UNC-Chapel Hill studying pain and opioids

258
Followers
296
Following
4
Posts
18.11.2024
Joined
Posts Following

Latest posts by Matan Geron @mgeron

Congratulations and good luck!!

18.12.2025 01:22 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Painkillers without the addiction? The new wave of non-opioid pain relief Pharma firms are developing drugs that avoid the brain’s opioid receptors to minimise the risks of dependence and overdoses, but not all experts are convinced

In January, the FDA approved a new non-opioid painkiller. CBP's GrΓ©gory Scherrer spoke with @theguardian.com about the new wave of developing non-opioid drugs for pain relief. Read here: www.theguardian.com/science/2025...

09.04.2025 18:54 πŸ‘ 5 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
A DREADD for the periphery - Nature Methods Nature Methods - A DREADD for the periphery

www.nature.com/articles/s41...

Nice blurb on our recent paper!

11.02.2025 20:57 πŸ‘ 5 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Structure-guided design of a peripherally restricted chemogenetic system Kang etΒ al. present HCAD, a peripherally restricted DREADD based on HCA2, with a chemical actuator that avoids crossing the blood-brain barrier and selectively reduces pain in mice. This system will enable the study of peripheral physiology without affecting the central nervous system.

Kang etΒ al. present HCAD, a peripherally restricted DREADD based on HCA2, with a chemical actuator that avoids crossing the blood-brain barrier and selectively reduces pain in mice.
www.cell.com/cell/fulltex...

02.01.2025 12:47 πŸ‘ 2 πŸ” 3 πŸ’¬ 1 πŸ“Œ 0
Preview
Gene Therapy Breakthrough Targets Peripheral Pain Pain is meant to be a defense mechanism. It creates a strong sensation to get us to respond to a stimulus and prevent ourselves from further harm

New from Rothlab!
www.miragenews.com/gene-therapy...

17.12.2024 22:41 πŸ‘ 6 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Please add me

11.12.2024 01:05 πŸ‘ 1 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0
Preview
Structure-guided design of a peripherally restricted chemogenetic system Kang etΒ al. present HCAD, a peripherally restricted DREADD based on HCA2, with a chemical actuator that avoids crossing the blood-brain barrier and selectively reduces pain in mice. This system will enable the study of peripheral physiology without affecting the central nervous system.

I am glad to share our recent work, now published in Cell! A @zenbrainest.bsky.social and Scherrer lab collaboration developing and validating a new peripherally restricted DREADD system! Great team work with Hye Jin Kang, Brian Krumm, @adrtas.bsky.social, and others
www.cell.com/cell/abstrac...

07.12.2024 01:41 πŸ‘ 14 πŸ” 6 πŸ’¬ 0 πŸ“Œ 0

New paper from the lab:
Structure-guided design of a peripherally restricted chemogenetic system
10.1016/j.cell.2024.11.001

03.12.2024 17:54 πŸ‘ 1 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Could you please add me? Thank you

20.11.2024 01:01 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

I started (at @katesadlerphd.bsky.social's suggestion, thanks Kate for pushing me) a pain neuroscience and pain research starter pack. I am sure I have missed many people so if I missed you, I am sorry, but please just ask me to add you in the thread below and I will do that. go.bsky.app/KboKNhg

18.11.2024 16:58 πŸ‘ 63 πŸ” 28 πŸ’¬ 38 πŸ“Œ 1